INMUNE BIO INC (INMB) Institutional Ownership Changes & 13F Activity

INMUNE BIO INC (INMB). Institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC Form 13F filings. This page analyzes institutional buying and selling activity, new holdings, and sold-out positions among tracked filers. Notable filers include Renaissance Technologies LLC.

Portfolio quarterNameTypeQuantityRemainingReported stock balance
Q1 2026Renaissance Technologies LLCSell-168,80017,000$19,210
Q4 2024Renaissance Technologies LLCBuy78,600185,800$867,686
Q3 2024Renaissance Technologies LLCBuy87,200107,200$577,808
Q2 2023Renaissance Technologies LLCSell-14,80020,000$182
Q1 2023Renaissance Technologies LLCBuy2,70034,800$225
Q2 2022Renaissance Technologies LLCSell-7,90032,100$284
Q3 2020Renaissance Technologies LLCBuy40,00040,000$412

Frequently asked questions about INMB activity

  • Which institutional owners are buying INMB?

    Institutional owners buying INMB include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.

  • What does "buy" mean in INMB activity?

    "Buy" means an investor increased their reported position in INMB compared to the prior reporting period. This reflects growing exposure to INMUNE BIO INC (INMB) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).

  • Is institutional interest in INMB increasing?

    Institutional interest in INMB can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.

Related INMB Institutional Insights